These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8856607)

  • 21. beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome.
    Lutters BC; de Groot PG; Derksen RH
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):958-62. PubMed ID: 12455190
    [No Abstract]   [Full Text] [Related]  

  • 22. [Expression of fusion proteins in beta(2)GP I gene-transfected HEp-2 cells and its clinical application].
    Lu L; Chen S; Gu Y; Shen N; Bao C; Wang Y; Yang C; Ye P; Yu C
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):413-7. PubMed ID: 11953211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the antiphospholipid/cofactor syndromes.
    Mercado U
    J Rheumatol; 1997 Aug; 24(8):1658-9. PubMed ID: 9263172
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
    Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations.
    Blank M; Shoenfeld Y
    Clin Immunol; 2004 Aug; 112(2):190-9. PubMed ID: 15240163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linseed oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome.
    Reifen R; Amital H; Blank M; Sklan D; Berkovich Z; Gershwin E; Shoenfeld Y
    J Autoimmun; 2000 Nov; 15(3):381-5. PubMed ID: 11040078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of antiphospholipid antibodies and their cofactors.
    Boffa MC; Berard M; Karmochkine M
    Clin Rev Allergy Immunol; 1995; 13(1):101-6. PubMed ID: 7648344
    [No Abstract]   [Full Text] [Related]  

  • 30. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.
    Meroni PL; Raschi E; Camera M; Testoni C; Nicoletti F; Tincani A; Khamashta MA; Balestrieri G; Tremoli E; Hess DC
    J Autoimmun; 2000 Sep; 15(2):237-40. PubMed ID: 10968917
    [No Abstract]   [Full Text] [Related]  

  • 31. The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making.
    Asherson RA
    Semin Thromb Hemost; 2008 Apr; 34(3):227-35. PubMed ID: 18720302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and expression of beta 2-glycoprotein 1 recognized by antiphospholipid antibodies and its clinical investigation.
    Chen S; Yang C; Shen N; Xue F
    Chin Med J (Engl); 1999 Jan; 112(1):67-71. PubMed ID: 11593645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells.
    Kornberg A; Renaudineau Y; Blank M; Youinou P; Shoenfeld Y
    Isr Med Assoc J; 2000 Jul; 2 Suppl():27-31. PubMed ID: 10909414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-beta2-glycoprotein I antibodies--when and how should they be measured?
    Reber G; de Moerloose P
    Thromb Res; 2004; 114(5-6):527-31. PubMed ID: 15507287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?
    Galli M
    Thromb Res; 2004; 114(5-6):597-601. PubMed ID: 15507297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune thrombophilic syndromes.
    Greaves M
    Haematologica; 1999 Jun; 84 Suppl EHA-4():32-5. PubMed ID: 10907462
    [No Abstract]   [Full Text] [Related]  

  • 37. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?
    Inanç M; Radway-Bright EL; Isenberg DA
    Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of antiphospholipid syndrome: From an historical perspective to the emergence of new autoantibodies].
    Ardila-Suarez O; Gómez-Puerta JA; Khamashta MA
    Med Clin (Barc); 2016 Jun; 146(12):555-60. PubMed ID: 26961394
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combined therapy in pregnancy with primary antiphospholipid syndrome].
    Szodoray P; Bacskó G; Lakos G; Zeher M
    Orv Hetil; 2003 Dec; 144(49):2411-3. PubMed ID: 14725207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Audit of laboratory investigation of antiphospholipid syndrome.
    Myers B; Dolan G; Gould J
    Br J Haematol; 2001 Oct; 115(1):229. PubMed ID: 11722438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.